Meletios Athanasios Dimopoulos
Overview
Explore the profile of Meletios Athanasios Dimopoulos including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
85
Citations
1117
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Stergiou I, Tsironis C, Papadakos S, Tsitsilonis O, Dimopoulos M, Theocharis S
Int J Mol Sci
. 2024 Feb;
25(4).
PMID: 38397043
Inflammasomes are multimeric protein complexes, sensors of intracellular danger signals, and crucial components of the innate immune system, with the NLRP3 inflammasome being the best characterized among them. The increasing...
12.
Fiste O, Mavrothalassitis E, Apostolidou K, Trika C, Liontos M, Koutsoukos K, et al.
Crit Rev Oncol Hematol
. 2024 Feb;
196:104296.
PMID: 38395242
Cyclin-dependent kinase 4 and 6 (CDK4/6) inhibitors have unprecedentedly advanced hormone-dependent breast cancer treatment paradigm. In the metastatic setting, ribociclib has consistently demonstrated survival benefit in pre-, peri-, and postmenopausal...
13.
Briasoulis A, Bampatsias D, Petropoulos I, Rempakos A, Patras R, Theodorakakou F, et al.
Eur Heart J Cardiovasc Imaging
. 2023 Dec;
25(5):698-707.
PMID: 38142437
Aims: Complete haematologic response to treatment for light chain cardiac amyloidosis (AL-CA) may lead to improvement of myocardial function and better outcomes. We sought to evaluate the effect of response...
14.
Liatsou E, Tatouli I, Mpozikas A, Pavlou M, Gakiopoulou H, Ntanasis-Stathopoulos I, et al.
J Clin Med
. 2023 Nov;
12(22).
PMID: 38002790
Tenofovir disoproxil fumarate (TDF) is a nucleotide reverse transcriptase inhibitor that has been widely used for the treatment of patients with human immunodeficiency virus (HIV) and hepatitis B virus (HBV)...
15.
Dimopoulos M, Hungria V, Radinoff A, Delimpasi S, Mikala G, Masszi T, et al.
Lancet Haematol
. 2023 Oct;
10(10):e801-e812.
PMID: 37793771
Background: Multiple myeloma remains incurable, and heavily pretreated patients with relapsed or refractory disease have few good treatment options. Belantamab mafodotin showed promising results in a phase 2 study of...
16.
Ntanasis-Stathopoulos I, Filippatos C, Gavriatopoulou M, Malandrakis P, Eleutherakis-Papaiakovou E, Spiliopoulou V, et al.
Diseases
. 2023 Sep;
11(3).
PMID: 37754319
tixagevimab/cilgavimab, distributed under the name "Evusheld", was the first available pre-exposure prophylaxis for COVID-19 other than vaccination. It received an EUA from the FDA after sufficient trial data showed efficacy...
17.
Defrancesco I, Ferretti V, Morel P, Kyriakou C, Kastritis E, Tohidi-Esfahani I, et al.
Hemasphere
. 2023 Jun;
7(6):e887.
PMID: 37283569
No abstract available.
18.
Fotiou D, Theodorakakou F, Gavriatopoulou M, Migkou M, Malandrakis P, Ntanasis-Stathopoulos I, et al.
Eur J Haematol
. 2023 May;
111(2):271-278.
PMID: 37218632
Objectives: Translocation t(11;14) is the most common cytogenetic abnormality in patients with systemic AL amyloidosis with prognostic and therapeutic relevance, which has not been clearly defined in the most recent...
19.
Fotiou D, Theodorakakou F, Malandrakis P, Ntanasis-Stathopoulos I, Gavriatopoulou M, Kanellias N, et al.
Leuk Lymphoma
. 2023 Apr;
64(6):1212-1215.
PMID: 37035896
No abstract available.
20.
Gkalea V, Fotiou D, Dimopoulos M, Kastritis E
Cancers (Basel)
. 2023 Jan;
15(2).
PMID: 36672429
The current review provides an overview of the thrombotic risk observed in patients with MG who do not otherwise require treatment. We discuss clinical and biomarker studies that highlight the...